Stakeholder meeting report: Chikungunya virus – recent outbreaks, vaccine development and the way forward

The International Vaccine Institute and Gorgas Institute (Gorgas Memorial Institute for Health Studies) organized the first Chikungunya Global Meeting in Panama City, Panama on December 12–13, 2023. Experts represented eight countries: Brazil, Colombia, Dominican Republic, India, Kenya, Panama, Paraguay, and Thailand. The aim of this meeting was for stakeholders to discuss chikungunya disease burden, vaccine deployment strategies, regulatory challenges, and access issues. This meeting highlighted lessons learned from recent chikungunya outbreaks and perspectives on ways forward in chikungunya research. Specifically, the following topics were discussed in the meeting: (i) lessons from recent chikungunya outbreaks and regional perspectives, (ii) chikungunya research priorities, (iii) chikungunya vaccine development, (iv) regulatory approval and pathways, (v) vaccine access, financing, and procurement, (vi) ways forward through a chikungunya vaccine initiative, and (vii) chikungunya research on how to analyse protection and long-term memory. Experts called for investments in vaccine deployment and a better understanding of the long-term economic impacts of chikungunya. Going forward, the experts recommended creation of a global chikungunya vaccine initiative to coordinate research and generate evidence to inform prevention and control programmes of chikungunya outbreaks and introduction of chikungunya vaccination in high-burden settings and regions at risk of chikungunya outbreaks.

Authors

Publication Details

Journal
Vaccine X
Published
2025-09-23
DOI
https://doi.org/10.1016/j.jvacx.2025.100730
Primary Topic
Mosquito-borne diseases and control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stakeholder meeting report: Chikungunya virus – recent outbreaks, vaccine development and the way forward

Jérôme H. Kim, Tanu Chawla, Robin Levis, Elsa Marina Rojas Garrido et al.
Vaccine X
Mosquito-borne diseases and control
article

Stakeholder meeting report: Chikungunya virus – recent outbreaks, vaccine development and the way forward

Jérôme H. Kim, Tanu Chawla, Robin Levis, Elsa Marina Rojas Garrido, Hyolim Kang, Eduardo Ortega‐Barría, Andrés Angelo Cadena Bonfanti, Celia Martínez de Cuéllar, Kaja Abbas, Gabriel González-Escobar, Fernando de la Hoz, I Fern aacute ndez Salas, Alain Bouckenooghe, Eva Lau, José Luis Di Fábio, Jean‐Paul Carrera, Lourdes Moreno, Melissa Malhame, Katelyn A Dinkel, Sushant Sahastrabuddhe, Wisit Tangkeangsirisin, K. Sumathy, Brenda G. Valente, Kléber Giovanni Luz, David Ferguson, Jamal I-Ching Sam, Megan Auzenbergs, Maya Malarski, George M. Warimwe, Juan Miguel Pascale, Wittawat Viriyabancha, Katrin Dubischar, Clara Maure, Sandra López-Vergès, Murat Öztürk, Rubina Bose, Juan Carlos Jaramillo, Libia Milena Hernandez Medina, Livia Vinhal, Lilián Porta, Yaniris Robles, Chris Hachu Gache, Maria del Pilar Hernández Svendblad, Maria Fernanda Thees, Sindy Pahola Pulgarin, Marlene Esquivel, Chrystal Samouge
article en

Abstract

The International Vaccine Institute and Gorgas Institute (Gorgas Memorial Institute for Health Studies) organized the first Chikungunya Global Meeting in Panama City, Panama on December 12–13, 2023. Experts represented eight countries: Brazil, Colombia, Dominican Republic, India, Kenya, Panama, Paraguay, and Thailand. The aim of this meeting was for stakeholders to discuss chikungunya disease burden, vaccine deployment strategies, regulatory challenges, and access issues. This meeting highlighted lessons learned from recent chikungunya outbreaks and perspectives on ways forward in chikungunya research. Specifically, the following topics were discussed in the meeting: (i) lessons from recent chikungunya outbreaks and regional perspectives, (ii) chikungunya research priorities, (iii) chikungunya vaccine development, (iv) regulatory approval and pathways, (v) vaccine access, financing, and procurement, (vi) ways forward through a chikungunya vaccine initiative, and (vii) chikungunya research on how to analyse protection and long-term memory. Experts called for investments in vaccine deployment and a better understanding of the long-term economic impacts of chikungunya. Going forward, the experts recommended creation of a global chikungunya vaccine initiative to coordinate research and generate evidence to inform prevention and control programmes of chikungunya outbreaks and introduction of chikungunya vaccination in high-burden settings and regions at risk of chikungunya outbreaks.

Vaccine XVol. 27
Openalex Percentile: Top 65%
Mosquito-borne diseases and control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.